1. Home
  2. XOMAP vs ATLCP Comparison

XOMAP vs ATLCP Comparison

Compare XOMAP & ATLCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XOMA Corporation 8.625% Series A Cumulative Perpetual Preferred Stock

XOMAP

XOMA Corporation 8.625% Series A Cumulative Perpetual Preferred Stock

SELL

Current Price

$26.45

Market Cap

0.0

Sector

Health Care

ML Signal

SELL

Logo Atlanticus Holdings Corporation 7.625% Series B Cumulative Perpetual Preferred Stock no par value per share

ATLCP

Atlanticus Holdings Corporation 7.625% Series B Cumulative Perpetual Preferred Stock no par value per share

HOLD

Current Price

$24.15

Market Cap

0.0

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
XOMAP
ATLCP
Founded
N/A
N/A
Country
United States
United States
Employees
13
417
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
XOMAP
ATLCP
Price
$26.45
$24.15
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
N/A
N/A
Earning Date
N/A
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
N/A
N/A
52 Week High
N/A
N/A

Technical Indicators

Market Signals
Indicator
XOMAP
ATLCP
Relative Strength Index (RSI) 45.10 50.89
Support Level $26.60 $23.87
Resistance Level $27.11 $24.20
Average True Range (ATR) 0.14 0.14
MACD -0.03 0.01
Stochastic Oscillator 0.00 46.87

Price Performance

Historical Comparison
XOMAP
ATLCP

About XOMAP XOMA Corporation 8.625% Series A Cumulative Perpetual Preferred Stock

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

About ATLCP Atlanticus Holdings Corporation 7.625% Series B Cumulative Perpetual Preferred Stock no par value per share

Atlanticus Holdings Corp invests in the financial services industry. It provides various credit and related financial services and products to or associated with the financially underserved consumer credit market. The operating business segments are the Credit as a Service (CaaS) and the Auto Finance segment. It generates maximum revenue from the Credit as a Service segment.

Share on Social Networks: